{
    "clinical_study": {
        "@rank": "137797", 
        "acronym": "GONDOPARK", 
        "arm_group": [
            {
                "arm_group_label": "Foot Mechanical Stimulation", 
                "arm_group_type": "Experimental", 
                "description": "The FMS stimulation will be given to all participants using GONDOLA equipment (Ecker Technologies Sagl, Switzerland)."
            }, 
            {
                "arm_group_label": "Footh Mechanical Stimulation", 
                "arm_group_type": "Sham Comparator", 
                "description": "The sham stimulation will be given to all participants using GONDOLA equipment (Ecker Technologies Sagl, Switzerland)."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this research study is to evaluate safety and effectiveness of Foot\n      Mechanical stimulation to improving Gait and Gait Related Disorders in Parkinson Disease and\n      Progressive Supranuclear Palsy both stable and with motor fluctuation."
        }, 
        "brief_title": "Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Idiopathic Parkinson's Disease", 
            "Progressive Supranuclear Palsy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Parkinson Disease", 
                "Supranuclear Palsy, Progressive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of idiopathic PD or PSP by UK Brain Bank criteria,\n\n          -  Able to walk 25 feet unassisted or with minimal assistance;\n\n          -  On stable doses of Parkinson's medications for at least 2 weeks prior to study onset;\n\n          -  Endurance sufficient to stand at least 20 minutes unassisted per patient report.\n\n        Exclusion Criteria:\n\n          -  Other significant neurological or orthopedic problems."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01815281", 
            "org_study_id": "GONDOPARK"
        }, 
        "intervention": {
            "arm_group_label": [
                "Foot Mechanical Stimulation", 
                "Footh Mechanical Stimulation"
            ], 
            "intervention_name": "Foot Mechanical Stimulation (GONDOLA)", 
            "intervention_type": "Device", 
            "other_name": "GONDOLA equipment (Ecker Technologies Sagl, Switzerland)."
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 20, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Maria Francesca De Pandis, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Cassino (FR)", 
                        "country": "Italy"
                    }, 
                    "name": "San Raffaele Cassino"
                }, 
                "investigator": [
                    {
                        "last_name": "Francesca De Pandis, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Patrizio Sale, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rome", 
                        "country": "Italy", 
                        "zip": "00163"
                    }, 
                    "name": "IRCCS San Raffaele Pisana"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Raffaello Furlan, MD"
                }, 
                "contact_backup": {
                    "last_name": "Franca Barbic, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Rozzano", 
                        "country": "Italy"
                    }, 
                    "name": "Humanitas Clinical and Research Center"
                }, 
                "investigator": [
                    {
                        "last_name": "Raffaello Furlan, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Franca Barbic, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease", 
        "other_outcome": [
            {
                "measure": "UNIFIED PARKINSON'S DISEASE RATING SCALE (UPDRS).", 
                "safety_issue": "Yes", 
                "time_frame": "Change from Baseline in UPDRS scores at 1 month follow up"
            }, 
            {
                "measure": "PROGRESSIVE SUPRANUCLEAR PALSY RATING SCALE (PSP RATING SCALES)", 
                "safety_issue": "Yes", 
                "time_frame": "Change from Baseline in PSP RATING SCALES scores  at 1 month follow up"
            }, 
            {
                "measure": "Functional Ambulation classification (FAC)", 
                "safety_issue": "Yes", 
                "time_frame": "Change from Baseline in FAC scores at 1 month follow up"
            }, 
            {
                "measure": "Walking handicap Scale (WHS)", 
                "safety_issue": "Yes", 
                "time_frame": "Change from Baseline in WHS scores at 1 month follow up"
            }
        ], 
        "overall_official": [
            {
                "affiliation": "IRCCS San Raffaele Pisana Rome Italy", 
                "last_name": "Fabrizio Stocchi, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "IRCCS San Raffaele Pisana Rome Italy", 
                "last_name": "Patrizio Sale, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "IRCCS San Raffaele Pisana Rome Italy", 
                "last_name": "Fabrizio Stocchi, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Time Up and Go test will be collected in OFF state 4 hour after oral assumption of levodopa at baseline (inclusion) (T0), before (T1-T3-T5-T7-T9-T11) and after all stimulation (T2-T4-T6-T8-T10) and endpoint (after 6 stimulation) (T12)  at the follow-up examination after 1 months from the treatments conclusion (T13).", 
            "measure": "Timed Up and Go.", 
            "safety_issue": "Yes", 
            "time_frame": "Change from Baseline in Timed Up and Go test at 1 month follow up."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01815281"
        }, 
        "responsible_party": {
            "investigator_affiliation": "IRCCS San Raffaele", 
            "investigator_full_name": "Patrizio Sale , MD", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "6 minuts walking test will be collected in OFF state 4 hour after oral assumption of levodopa at baseline (inclusion) (T0), before (T1-T3-T5-T7-T9-T11) and after all stimulation (T2-T4-T6-T8-T10) and endpoint (after 6 stimulation) (T12) at the follow-up examination after 1 months from the treatments conclusion (T13).", 
                "measure": "6 minuts walking test.", 
                "safety_issue": "Yes", 
                "time_frame": "Change from Baseline in gait speed at 1 month  follow up"
            }, 
            {
                "description": "Gait Analysis will be collected in OFF state 4 hour after oral assumption of levodopa at baseline (inclusion) (T0), before (T1-T3-T5-T7-T9-T11) and after all stimulation (T2-T4-T6-T8-T10) and endpoint (after 6 stimulation) (T12) at the follow-up examination after 1 months from the treatments conclusion (T13).", 
                "measure": "Gait Parameters", 
                "safety_issue": "Yes", 
                "time_frame": "Change from Baseline in Gait Parameters at 1 month follow up"
            }, 
            {
                "measure": "FREEZING OF GAIT QUESTIONNAIRES", 
                "safety_issue": "Yes", 
                "time_frame": "Change from Baseline in FREEZING OF GAIT QUESTIONNAIRES at 1 month follow up."
            }, 
            {
                "measure": "THE PARKINSON'S DISEASE QUESTIONNAIRE  (PDQ-39)", 
                "safety_issue": "Yes", 
                "time_frame": "Change from Baseline in PDQ-39 at 1 month follow up"
            }
        ], 
        "source": "IRCCS San Raffaele", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "IRCCS San Raffaele", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}